P90.03 A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2021-03, Vol.16 (3), p.S696-S696
Main Authors: Spira, A., Riely, G., Lawler, W., Shum, M., Socinski, M., Yanagihara, R., Roshan, S., Kheoh, T., Christensen, J., Chao, R., Janne, P., Garassino, M.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2021.01.1286